Literature DB >> 7400306

Structure, immunology, and cell reactivity of low density lipoprotein from umbilical vein of a newborn type II homozygote.

W Patsch, J L Witztum, R Ostlund, G Schonfeld.   

Abstract

In this report we compare the cord blood lipoproteins of a newborn boy homozygote who has low density lipoprotein (LDL) receptor-defective familial hypercholesterolemia (FH) with the lipoproteins from cord blood of normal newborns. Plasma LDL-cholesterol and apoprotein (Apo)B were 612 and 233 mg/dl (vs. 31+/-16 and 24+/-12 mg/dl, respectively, for normals, n = 21). LDL-cholesterol/ApoB ratio was 2.6 vs. 1.4+/-0.5. Levels of ApoA-I, ApoA-II, and HDL-cholesterol were similar to normal cord plasma. Thus, the lipoprotein abnormality is apparent at birth and is definitely present in LDL. Abnormalities in other lipoprotein, lipid, and in plasma apoprotein levels were not detected. On zonal ultracentrifugation, FH LDL was comprised of two populations (LDL(a) and LDL(b)), both faster floating than normal cord LDL (LDL(c)). This difference was due to the larger diameters of the particles on electron microscopy (LDL(a) = 276A+/-32 and LDL(b) = 260A+/-38 vs. LDL(c) = 237A+/-26, n = 200 each, mean+/-1 SD), and their higher contents of lipids relative to protein (86 and 82% vs. 74%, LDL(a), LDL(b), and LDL(c), respectively). More than 94% of the protein in both the FH and the normal preparations consisted of ApoB. FH LDL were more effective than control LDL in competing with (125)I-LDL (adult) for limiting amounts of anti-LDL antibodies in radioimmunoassay. FH LDL also competed more effectively for binding to LDL receptors on cultured fibroblasts at 4 degrees C, and FH LDL also delivered more cholesterol into the cells. Cells grown in lipoprotein-deficient serum contained 44+/-2 mug cholesterol/mg cell protein, incubation of cells for 18 h at 37 degrees C in 5 mug/ml FH LDL (protein) or in normal LDL raised cellular cholesterol levels to 75+/-2 and 60+/-2 mug/mg, respectively.LDL isolated from the FH patient's plasma at 6 mo of age and from his brother's plasma (a 5-yr-old boy FH homozygote) were similar to LDL isolated from normolipemic subjects in flotation properties, chemical composition, and immunochemical and cell reactivity. The fact that differences between normal cord LDL and FH cord LDL were present at birth, but that the differences between control and FH LDL were no longer present postnatally suggests that the altered immunologic and cell interactive properties of FH cord LDL were probably related to its unusually high contents of core lipids.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7400306      PMCID: PMC371513          DOI: 10.1172/JCI109825

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

1.  Labelling of plasma proteins with radioactive iodine.

Authors:  A S MCFARLANE
Journal:  Biochem J       Date:  1956-01       Impact factor: 3.857

2.  A genetic determinant of the phenotypic variance of the molecular weight of low density lipoprotein.

Authors:  W R Fisher; M G Hammond; M C Mengel; G L Warmke
Journal:  Proc Natl Acad Sci U S A       Date:  1975-06       Impact factor: 11.205

3.  Isolation of subfractions of human very low density lipoproteins by zonal ultracentrifugation.

Authors:  W Patsch; J R Patsch; G M Kostner; S Sailer; H Braunsteiner
Journal:  J Biol Chem       Date:  1978-07-25       Impact factor: 5.157

4.  Role of microtubules in low density lipoprotein processing by cultured cells.

Authors:  R E Ostlund; B Pfleger; G Schonfeld
Journal:  J Clin Invest       Date:  1979-01       Impact factor: 14.808

5.  Separation of the main lipoprotein density classes from human plasma by rate-zonal ultracentrifugation.

Authors:  J R Patsch; S Sailer; G Kostner; F Sandhofer; A Holasek; H Braunsteiner
Journal:  J Lipid Res       Date:  1974-07       Impact factor: 5.922

6.  Neonatal diagnosis of familial type-II hyperlipoproteinaemia.

Authors:  P O Kwiterovich; R I Levy; D S Fredrickson
Journal:  Lancet       Date:  1973-01-20       Impact factor: 79.321

7.  Prenatal diagnosis of homozygous familial hypercholesterolaemia. Expression of a genetic receptor disease in utero.

Authors:  M S Brown; P T Kovanen; J L Goldstein; R Eeckels; K Vandenberghe; H van den Berghe; J P Fryns; J J Cassiman
Journal:  Lancet       Date:  1978-03-11       Impact factor: 79.321

8.  Metabolic studies in familial hypercholesterolemia. Evidence for a gene-dosage effect in vivo.

Authors:  D W Bilheimer; N J Stone; S M Grundy
Journal:  J Clin Invest       Date:  1979-08       Impact factor: 14.808

9.  The structure of human high density lipoprotein and the levels of apolipoprotein A-I in plasma as determined by radioimmunoassay.

Authors:  G Schonfeld; B Pfleger
Journal:  J Clin Invest       Date:  1974-08       Impact factor: 14.808

10.  Procedure for determination of free and total cholesterol in micro- or nanogram amounts suitable for studies with cultured cells.

Authors:  W Gamble; M Vaughan; H S Kruth; J Avigan
Journal:  J Lipid Res       Date:  1978-11       Impact factor: 5.922

View more
  2 in total

1.  Familial hypercholesterolemia. Evidence for a newly recognized mutation determining increased fibroblast receptor affinity but decreased capacity for low density lipoprotein in two siblings.

Authors:  R E Ostlund; R A Levy; J L Witztum; G Schonfeld
Journal:  J Clin Invest       Date:  1982-10       Impact factor: 14.808

2.  Diversity in expression of heterozygous familial hypercholesterolemia. Characterization of a unique kindred.

Authors:  R A Levy; R E Ostlund; C F Semenkovich; J L Witztum
Journal:  J Clin Invest       Date:  1986-07       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.